Suppr超能文献

立体定向适形调强放射治疗三叉神经痛-治疗结果的回顾性双机构研究。

LINAC stereotactic radiosurgery for trigeminal neuralgia -retrospective two-institutional examination of treatment outcomes.

机构信息

Department of Radiosurgery and Stereotactic Radiotherapy, MediClin Robert Janker Clinic and MediClin MVZ Bonn, Villenstrasse 8, 53129, Bonn, Germany.

Department of Neurosurgery, BG University Hospital Bergmannsheil, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany.

出版信息

Radiat Oncol. 2018 Aug 22;13(1):153. doi: 10.1186/s13014-018-1102-2.

Abstract

BACKGROUND

In this pooled 2-center series LINAC radiosurgery (SRS) has been applied as a treatment option for a subset of refractory trigeminal neuralgia (TN) patients. This study approached to retrospectively assess the efficacy and safety of LINAC SRS and to provide a brief overview addressed to the technical development from frame-based towards frameless robotic SRS.

METHODS

From 2001 to 2017 n = 55 patients (pts) were treated, n = 28 were female (51%), mean age: 66 years (range 36-93 years); TN etiology: 37 classic TN, 15 multiple sclerosis (MS)-related TN, 2 symptomatic TN, and 1 atypical TN. Previous treatment was present in n = 35 (63.6%) pts. (some multiple or combined) with n = 23 microsurgical vascular decompression and n = 17 percutaneous retrogasserian rhizotomy. A 6 MV LINAC (4-5 mm collimators) was applied in all pts. (n = 26 framebased - n = 29 frameless robotic). The dorsal root entry zone (DREZ) was targeted in n = 35 cases and the retrogasserian target in n = 20 pts. with a homogeneous dose for the entire study cohort (90 Gy). SRS outcome was measured using the Barrow Neurological Institute (BNI) score for pain and hypaesthesia and statistically evaluated by univariate and multivariate analyzes.

RESULTS

Mean follow-up (FU) was 30 months (2 lost FU); the total rate of post SRS BNI pain I-IIIa (=painfree w or w/o medication) was 69% (88% for the classic TN pts), 29% (38.8% classic TN) were classified as BNI pain I-II (=painfree w/o medication). A BNI hypaesthesia II-III was present in 9.4% (n = 5) and BNI hypaesthesia IV in n = 2. Between groups analysis demonstrated no correlation of SRS responsiveness with age, gender, MS- or not MS-associated TN, previous surgery, framebased/frameless robotic SRS. DREZ targeting significantly better suppressed TN compared to RG targeting (p = 0.01). Additionally, a statistical trend for a better BNI pain outcome (p = 0.07) along with a significant increase in BNI hypaesthesia (p = 0.01) was found when using a larger partial trigeminal 70 Gy volume.

CONCLUSION

Our retrospective analysis support LINAC SRS as an effective and safe treatment option in TN. Frameless robotic SRS of TN is safe when using a dedicated LINAC system. A target definition closer to the brainstem and tendencially a larger target volume were associated with a better outcome for pain.

摘要

背景

在这项汇总的 2 中心系列研究中,直线加速器放射外科手术(SRS)已被用作一组难治性三叉神经痛(TN)患者的治疗选择。本研究旨在回顾性评估 LINAC SRS 的疗效和安全性,并简要概述从基于框架到无框架机器人 SRS 的技术发展。

方法

2001 年至 2017 年,共有 55 例患者(pts)接受了治疗,其中 28 例为女性(51%),平均年龄为 66 岁(范围为 36-93 岁);TN 病因:37 例经典 TN、15 例多发性硬化症(MS)相关 TN、2 例症状性 TN 和 1 例非典型 TN。35 例(63.6%)患者既往有治疗史(部分患者多次或联合治疗),其中 23 例行微血管减压术,17 例行经皮三叉神经根切断术。所有患者均采用 6 MV LINAC(4-5mm 准直器)治疗(n=26 例基于框架,n=29 例无框架机器人)。35 例患者以背根入口区(DREZ)为靶点,20 例患者以经颅神经根为靶点,整个研究队列的均匀剂量为 90Gy。采用巴罗神经研究所(BNI)评分评估 SRS 结果,评估疼痛和感觉迟钝,并通过单变量和多变量分析进行统计学评估。

结果

中位随访时间(FU)为 30 个月(2 例失访);SRS 后 BNI 疼痛 I-IIIa 总发生率(无痛且无需药物治疗的患者)为 69%(经典 TN 患者为 88%),BNI 疼痛 I-II 发生率(无需药物治疗的无痛患者)为 29%(经典 TN 患者为 38.8%)。9.4%(n=5)患者存在 BNI 感觉迟钝 II-III 级,2 例患者存在 BNI 感觉迟钝 IV 级。组间分析显示,SRS 反应性与年龄、性别、MS 相关或不相关的 TN、既往手术、基于框架/无框架机器人 SRS 之间无相关性。与 RG 靶向治疗相比,DREZ 靶向治疗显著改善了 TN(p=0.01)。此外,当使用更大的三叉神经 70Gy 部分体积时,发现 BNI 疼痛结局(p=0.07)有更好的统计学趋势,以及 BNI 感觉迟钝(p=0.01)显著增加。

结论

我们的回顾性分析支持 LINAC SRS 作为 TN 的有效且安全的治疗选择。当使用专用 LINAC 系统时,无框架机器人 SRS 治疗 TN 是安全的。与脑干更接近的靶点定义和倾向于更大的靶点体积与疼痛结局的改善相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f310/6106738/3df256d4a8a7/13014_2018_1102_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验